Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
 
 
 
  Blog Calendar  
 
SuMoTuWeThFrSa
   1234
567891011
12131415161718
19202122232425
262728293031 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Raymond Anton, Medical University of South Carolina, Charleston, SC

Catasys Health - Saturday, August 01, 2009

Randomized, Stratified, Double-Blind, Placebo-Controlled Trial of Flumazenil and Gabapentin for the Treatment of Alcohol Dependence
Published in the Journal of Clinical Psychopharmacology, August 2009; 29(4):334-342.

 The OnTrak Medical Treatment Program achieved a significant reduction in use and cravings among members with symptoms of alcohol withdrawal (>6 CIWA) when compared to placebo.

Among members with more symptoms of alcohol withdrawal, the Prometa group experienced: ยป More
| 1 |

 
 
  Tags
 
data mining high-utilizing behavioral health care services alcohol narcotic withdrawal recovery network overdose ER opioid antagonist physician- patient relations drug overdose cigarettes health insurance stress vicodin drug abuse morphine nicotine sobriety depression meth flumazenil craving score alcohol dependence prescriptions muscle relaxant sober heroin alcohol treatment Catasys predictive modeling Harold Urschel gabapentin opioid overdose OxyContin SD health insurance contract PTSD methamphetamine dependence reduction in use substance dependence costs addiction treatment medical double-blind binge drinking diabetes reducing craving vivitrol opiod-based trauma hospitalizations oxycodone drug use care coaching behavioral health care OnTrak prometa Raymond Anton substance dependence health insurance SD members anxiety drug addicts opiod abuse Opioid Prescribing drinking social network addiction primary care hydrocodone Journal of Psychopharmacology facebook codeine UnitedHealthcare pain pills craving behavioral healthcare services opioid-drug interactions placebo ADHD opioid abuse methadone alcohol drinking smoking painkillers methamphetamine addict marijuana Health Care Utilization reduction in craving communication CIWA percocet opiates alcoholism dependence issues naloxone mental health Opioid Treatment recovery pain medication cocaine substance dependence psychosocial ADD emergency room relapse bipolar disorder post-traumatic stress disorder pain killers buprenorphine stratified over-the-counter substances sugar drug addiction medical and behavioral costs treatment randomized health plan fentanyl behavioral healthcare hospital urine drug screen suboxone mental illness Research Across America medical costs drug treatment health reform identification behavioral health relapse prevention stimulants Co Occurring Disorders opioid depression screening chronic pain cocaine treatment Opioid Medications substance use disorder placebo-controlled
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy/Photo Disclaimer
 
  Copyright © 2013 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025 | Toll Free: 1-866-517-1414